← Back to Search

Blood Glucose Monitoring for Gestational Diabetes

N/A
Waitlist Available
Led By Stephen Chasen, MD
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Pregnant patients with singleton gestation who are ≥ 18 years of age
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at time of delivery
Awards & highlights

Study Summary

This trial will help researchers understand if gestational diabetics who perform 1-hour postprandial blood glucose testing are more likely to adhere to their treatment plan than those who perform 2-hour postprandial blood glucose testing.

Who is the study for?
This trial is for pregnant women over 18 with a single pregnancy, diagnosed with gestational diabetes (GDM) after 24 weeks using the two-step screening method. It's not for those who had GDM before 24 weeks or have pre-gestational Type 1 or Type 2 diabetes.Check my eligibility
What is being tested?
The study compares how well patients with GDM stick to blood sugar testing if they check it one hour versus two hours after eating. The goal is to see which timing leads to better adherence in completing glucose logs.See study design
What are the potential side effects?
Since this trial involves standard blood glucose monitoring, there are no direct side effects from interventions like drugs; however, participants may experience discomfort from frequent finger pricks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am pregnant with one baby and am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at time of delivery
This trial's timeline: 3 weeks for screening, Varies for treatment, and at time of delivery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rate of adherence
Secondary outcome measures
Medication Therapy Management
Neonatal birthweight
Number of NICU admissions
+19 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: 2-hour post-prandial blood glucose monitoring ArmExperimental Treatment1 Intervention
Arm in which participants are randomized to blood glucose monitoring at 2 hours after eating.
Group II: 1-hour post-prandial blood glucose monitoring ArmExperimental Treatment1 Intervention
Arm in which participants are randomized to blood glucose monitoring at 1 hour after eating.

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor
1,052 Previous Clinical Trials
1,329,732 Total Patients Enrolled
Stephen Chasen, MDPrincipal InvestigatorWeill Medical College of Cornell University
1 Previous Clinical Trials
34 Total Patients Enrolled

Media Library

1 hour Blood glucose monitoring Clinical Trial Eligibility Overview. Trial Name: NCT05062460 — N/A
Gestational Diabetes Research Study Groups: 1-hour post-prandial blood glucose monitoring Arm, 2-hour post-prandial blood glucose monitoring Arm
Gestational Diabetes Clinical Trial 2023: 1 hour Blood glucose monitoring Highlights & Side Effects. Trial Name: NCT05062460 — N/A
1 hour Blood glucose monitoring 2023 Treatment Timeline for Medical Study. Trial Name: NCT05062460 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are recruitment efforts currently underway for this trial?

"According to the clinicaltrials.gov page, this medical study is currently not in search of participants. It was initially posted on July 15th 2021 and subsequently revised on July 29 2022; despite its conclusion, there are presently 103 other trials seeking people's participation."

Answered by AI
~8 spots leftby Jun 2024